Pacira Biosciences, Inc. (PCRX)
25.16
+0.30
(+1.21%)
USD |
NASDAQ |
Aug 25, 12:34
Pacira Biosciences Price to Book Value : 1.491 for Aug. 25, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 1.473 |
| August 21, 2026 | 1.462 |
| August 20, 2026 | 1.412 |
| August 19, 2026 | 1.444 |
| August 18, 2026 | 1.422 |
| August 17, 2026 | 1.377 |
| August 14, 2026 | 1.363 |
| August 13, 2026 | 1.374 |
| August 12, 2026 | 1.404 |
| August 11, 2026 | 1.445 |
| August 10, 2026 | 1.448 |
| August 07, 2026 | 1.483 |
| August 06, 2026 | 1.516 |
| August 05, 2026 | 1.474 |
| August 04, 2026 | 1.637 |
| August 03, 2026 | 1.595 |
| July 31, 2026 | 1.565 |
| July 30, 2026 | 1.598 |
| July 29, 2026 | 1.564 |
| July 28, 2026 | 1.589 |
| July 27, 2026 | 1.569 |
| July 24, 2026 | 1.534 |
| July 23, 2026 | 1.537 |
| July 22, 2026 | 1.516 |
| July 21, 2026 | 1.528 |
| Date | Value |
|---|---|
| July 20, 2026 | 1.502 |
| July 17, 2026 | 1.518 |
| July 16, 2026 | 1.517 |
| July 15, 2026 | 1.501 |
| July 14, 2026 | 1.482 |
| July 13, 2026 | 1.514 |
| July 10, 2026 | 1.51 |
| July 09, 2026 | 1.511 |
| July 08, 2026 | 1.512 |
| July 07, 2026 | 1.530 |
| July 06, 2026 | 1.516 |
| July 02, 2026 | 1.505 |
| July 01, 2026 | 1.483 |
| June 30, 2026 | 1.504 |
| June 29, 2026 | 1.508 |
| June 26, 2026 | 1.517 |
| June 25, 2026 | 1.465 |
| June 24, 2026 | 1.440 |
| June 23, 2026 | 1.413 |
| June 22, 2026 | 1.365 |
| June 18, 2026 | 1.342 |
| June 17, 2026 | 1.361 |
| June 16, 2026 | 1.372 |
| June 15, 2026 | 1.367 |
| June 12, 2026 | 1.382 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Zimmer Biomet Holdings, Inc. | 1.510 |
| Liquidia Corp. | 32.39 |
| Johnson & Johnson | 7.734 |
| Merck & Co., Inc. | 9.083 |
| ANI Pharmaceuticals, Inc. | 2.861 |
Price to Book Value Related Metrics
| PE Ratio | 72.49 |
| PS Ratio | 1.422 |
| Price to Free Cash Flow | 5.909 |
| Price | 25.16 |
| Earnings Yield | 1.38% |
| Market Cap | 1.002B |
| Operating PE Ratio | 38.39 |
| Normalized PE Ratio | 51.64 |